Search research articles
Contact Us
Filters
Showing results (51-60 of 138) with videos related to
Page
of 14
Sort By:
Journal of Inflammation Research
|
February 19, 2026
IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?
Matteo Megna, Michela D'Agostino, Federica Feo, et al.
Clinical, Cosmetic and Investigational Dermatology
|
February 13, 2023
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
Luca Potestio, Ilaria Piscitelli, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
October 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study
Sara Cacciapuoti, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 15, 2024
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
Luca Potestio, Fabrizio Martora, Giuseppe Lauletta, et al.
Clinical and Experimental Dermatology
|
April 24, 2024
Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced
Matteo Megna, Angelo Ruggiero, Ginevra Torta, et al.
Clinical, Cosmetic and Investigational Dermatology
|
March 13, 2024
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
June 4, 2024
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report
Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio, et al.
Journal of Clinical Medicine
|
September 13, 2025
The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence
Giuseppe Lauletta, Daniele Cecere, Luca Potestio, et al.
Clinical and Experimental Dermatology
|
June 26, 2026
Treatment Trajectories and Dose Optimization of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Real-World Landmark Analysis
Maddalena Napolitano, Chiara Palagiano, Cataldo Patruno, et al.
Expert Opinion on Pharmacotherapy
|
November 18, 2021
Alitretinoin for the treatment of severe chronic eczema of the hands
Maddalena Napolitano, Luca Potestio, Mario De Lucia, et al.
Page
of 14
Search research articles
Search
Showing results (51-60 of 138) with videos related to
Sort By:
Page
of 14
Journal of Inflammation Research
|
February 19, 2026
IL-23 Inhibitors in Psoriasis: What Have We Learnt so Far?
Matteo Megna, Michela D'Agostino, Federica Feo, et al.
Clinical, Cosmetic and Investigational Dermatology
|
February 13, 2023
Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
Luca Potestio, Ilaria Piscitelli, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology
|
October 14, 2024
Impact of tildrakizumab on the quality of life of patients with moderate-to-severe psoriasis: a 36-week prospective monocentric real-life observational study
Sara Cacciapuoti, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
April 15, 2024
The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials
Luca Potestio, Fabrizio Martora, Giuseppe Lauletta, et al.
Clinical and Experimental Dermatology
|
April 24, 2024
Efficacy and safety of bimekizumab in real-world psoriasis management: data from patients who are biologic-naive vs. biologic-experienced
Matteo Megna, Angelo Ruggiero, Ginevra Torta, et al.
Clinical, Cosmetic and Investigational Dermatology
|
March 13, 2024
Long-Term Efficacy of Guselkumab in an Adolescent Hidradenitis Suppurativa Patients: A Case Report
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Clinical, Cosmetic and Investigational Dermatology
|
June 4, 2024
Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration - A Case Report
Fabrizio Martora, Maria Carmela Annunziata, Luca Potestio, et al.
Journal of Clinical Medicine
|
September 13, 2025
The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence
Giuseppe Lauletta, Daniele Cecere, Luca Potestio, et al.
Clinical and Experimental Dermatology
|
June 26, 2026
Treatment Trajectories and Dose Optimization of Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A Real-World Landmark Analysis
Maddalena Napolitano, Chiara Palagiano, Cataldo Patruno, et al.
Expert Opinion on Pharmacotherapy
|
November 18, 2021
Alitretinoin for the treatment of severe chronic eczema of the hands
Maddalena Napolitano, Luca Potestio, Mario De Lucia, et al.
Page
of 14